Detection of the Serum Level of C3 and C4 Among Patients with Urinary Tract Infection
Keywords:biosynthesis, uropathogens, E. coli, ELISA
The current study aims to determine the prevalence of bacterial urinary tract infection (UTI) and estimate the serum levels of C3 and C4 in UTI patients. This study had been included 350 samples (blood and urine) obtained from outpatients suspected of having UTI from Baquba-Teaching Hospital. The detection of causative Bacteria was done using an automatic VITEK 2 system. A sample of 350 urine was taken, and after diagnoses, it found that only 205 (58.5%) had UTI; 123 (as 60 %) with a positive culture of bacteria, and 82 (as 40%) with negative culture of bacteria. Among the Gram-negative bacteria, mostly isolated were Escherichia coli 44 (resembles 35.7%), K. Pneumonia 18 (resembles 14.6%), P. aeruginosa 8 (resembles 6.5%) 2 (resembles 1.6 %) which was diagnosed as Burkholderia cepacia. Gram-positive organisms included 51 (as 41.4%) of total positive results, divided into 37 isolates (30.08%) of Staphylococcus spp. and 14 isolates (11.3%) of Enterococcus spp. Immunological parameters, which were included the determination of serum levels of C3 with C4 showed that lower levels of both C3 and C4 in UTI patients compared with the control group (18.48±1.3 versus 19.4 ± 2.9pg/ml) and (0.739±0.257 versus 1.205±0.259 pg/ml) respectively. In conclusion, E. coli, K. pneumoniae and S. aureus were found to be the highly isolated bacteria in UTI cases, with decreased levels of C3 and C4 in serum in UTI patients.
Bonkat, G., Pickard, R., Bartoletti, R., Bruyère, F., Geerlings, S. E., Wagenlehner, F., & Wullt, B. (2017). EAU guidelines on urological infections. European Association of Urology, 22-26.
Flores-Mireles, A. L., Walker, J. N., Caparon, M., and Hultgren, S. J. (2015). Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269–284.
Al-Fatlawi, S. F. N. (2020). Molecular Analysis of Fim H Gene from Uropathogenic Escherichia. coli (Doctoral dissertation, Ministry of Higher Education).
Kumar, A. R. (2013). Antimicrobial sensitivity pattern of Klebsiella pneumonia isolated from pus from tertiary care hospital and issues related to the rational selection of antimicrobials. Journal of Chemical and Pharmaceutical Research, 5(11):326-331.
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., ... & Soper, D. E. (2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical infectious diseases, 52(5), e103-e120.
Cash, P. (2014). Proteomic analysis of uropathogenic Escherichia coli. Expert review of proteomics, 11(1), 43-58.
Salvatore S., Cattoni E., Siesto G., Serati M., Sorice P and Torella M. (2011). Urinary tract infections in women.European Journal of Obstetrics, Gynaecology, and Reproductive Biology 156: 131–136.
Nguyen, H. T. (2004). Bacterial infections of the genitourinary tract. Tanagho EA, McAninch JW. Smith’s General Urology. New York: McGraw-Hill, 16, 203-227.
Momoh, A. R. M., Orhue, P. O., Idonije, O. B., Oaikhena, A. G., Nwoke, E. O., & Momoh, A. A. (2011). The antibiogram types of Escherichia coli isolated from suspected urinary tract infection samples. J Microbiol Biotech Res, 1(3), 57-65.
Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., ... & Calandra, T. (2011). Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood, The Journal of the American Society of Hematology, 117(4), 1205-1217.
Harju, K. (2004). Toll-like receptors (TLR) 4 and 2 regulate the innate immune response. Oulun Yliopisto, Oulu.
Heesterbeek, D. A., Angelier, M. L., Harrison, R. A., & Rooijakkers, S. H. (2018). Complement and bacterial infections: from molecular mechanisms to therapeutic applications. Journal of innate immunity, 10(5-6), 455-464.
Jayalakshmi, J., & Jayaram, V. S. (2008). Evaluation of various screening tests to detect asymptomatic bacteriuria in pregnant women. Indian Journal of Pathology and Microbiology, 51(3), 379.
Al-Jumaily, S. F. S., Al-Taai, H. R. R., & Al-Dulaimi, A. A. (2019). Study of Phenotyping and Genotyping Characterization of Methicillin Resistant Staphylococcus Aureus Isolates. Indian Journal of Forensic Medicine & Toxicology, 13(4), 875-880.
Ahmed, S. S., Shariq, A., Alsalloom, A. A., Babikir, I. H., & Alhomoud, B. N. (2019). Uropathogens and their antimicrobial resistance patterns: Relationship with urinary tract infections. International journal of health sciences, 13(2), 48.
AL-Kubaisy,R.S.(2013).Prevalence of Virulence Factors and Antibiotics Resistance Among Locally Isolated Uropathogenic E. coli from Pregnant Women .Master ,science college, AL -Mustansiriyah University.
Al-Jebouri, M. M., & Mdish, S. A. (2013). Antibiotic resistance pattern of bacteria isolated from patients of urinary tract infections in Iraq.
Kareem, I. J., & Rasheed, I. Y. (2011). Antibiotic susceptibilities of gram negative aerobic bacteria isolated from urinary tract infections in community. Iraqi J Med Sci, 9.
Raheem, R. S. A., Hussein, M. A., & Al-Din, N. I. (2019). Causative organism of urinary tract infection and drug resistance in children at child’s Central Teaching Hospital in Baghdad City. JPMA, 69.21. Yamik, D. Y. (2019). PREVALENCE OF URINARY TRACT INFECTIONS AND ANTIBIOTIC RESISTANCE OF UROPATHOGENS ISOLATED FROM PATIENTS IN THE TAMALE TEACHING AND CENTRAL HOSPITALS (Doctoral dissertation).
Ifeanyichukwu, I., Emmanuel, N., Chika, E., Anthonia, O., Esther, U., Ngozi, A., & Justina, N. (2013). Frequency and antibiogram of uropathogens isolated from urine samples of HIV infected patients on antiretroviral therapy. American Journal of BioScience, 1(3), 50-53.
Shahidul, K. M., Farahnaaz, F., & Sunjukta, A. (2013). Determination of antibiotic resistance pattern of biofilm producing pathogenic bacteria associated with UTI. International Journal of Drug Development and Research, 5(4), 312-319.
Xavier, T. F., Auxilia, A., & Kannan, M. (2015). Isolation and characterization of UTI pathogens from HIV positive patients of Karur District, Tamil Nadu, India. International Journal of Current Microbiology and Applied Sciences, 4(1), 558-563.
Shanmugam, K., Thyagarajan, R., Katragadda, R., Vajravelu, L., & Lakshmy, A. (2017). Biofilm formation and Extended Spectrum Beta Lactamases (ESBL) producers among the gram negative bacteria causing Urinary tract infections. Int J Med Microbiol Trop Dis, 3(3), 86-90.
Nigussie, D., & Amsalu, A. (2017). Prevalence of uropathogen and their antibiotic resistance pattern among diabetic patients. Turkish Journal of Urology, 43(1), 85.
Al-khafaf, D. M. (2012). Study of some microbial and Immunological parameter in patients with Urinary Tract Infection in Al-Diwanyia city. Al-Qadisiyah Medical Journal, 8(13), 28-38.
Ayoade, F., Osho, A., Fayemi, S. O., Oyejide, N. E., & Ibikunle, A. A. (2013). Unusually high prevalence of asymptomatic bacteriuria among male university students on Redemption Camp, Ogun State, Nigeria. African Journal of Clinical and Experimental Microbiology, 14(1), 19-22.
Hussein, N. R., Daniel, S., Salim, K., & Assafi, M. S. (2017). Urinary tract infections and antibiotic sensitivity patterns among women referred to Azadi teaching hospital, Duhok, Iraq. Avicenna journal of clinical microbiology and infection, 5(2), 27-30.
Desai, P., Ukey, P. M., Chauhan, A. R., Malik, S., & Mathur, M. (2012). Etiology and antimicrobial resistance pattern of uropathogens in a hospital from suburban mumbai. Int J Biol Med Res, 3(3), 2007-12.
Kibret, M., & Abera, B. (2014). Prevalence and antibiogram of bacterial isolates from urinary tract infections at Dessie Health Research Laboratory, Ethiopia. Asian Pacific journal of tropical biomedicine, 4(2), 164-168.
Kireçci, E., Sleman, D. M., Ahmed, D. Y., Rahman, D. B., & Yazdee, F. S. (2015). Identification of the bacterial types that cause urinary tract infection and antimicrobial susceptibility in Erbil, Iraq. Sky J Microbiol Res, 1, 011-014.
Niveditha, S., Pramodhini, S., Umadevi, S., Kumar, S., & Stephen, S. (2012). The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). Journal of clinical and diagnostic research: JCDR, 6(9), 1478.
Syukri, M., Imran, I., Harapan, H., Sja'bani, M., Astuti, I., & Soesatyo, M. H. (2015). Comparison of serum C3 complement levels between young women with recurrent urinary tract infection and healthy women. Alexandria Journal of Medicine, 51(1), 35-39..
Figueroa, J. E., & Densen, P. (1991). Infectious diseases associated with complement deficiencies. Clinical microbiology reviews, 4(3), 359-395.
Ram, S., Lewis, L. A., & Rice, P. A. (2010). Infections of people with complement deficiencies and patients who have undergone splenectomy. Clinical microbiology reviews, 23(4), 740-780.
S. Reis, E., Falcao, D. A., & Isaac, L. (2006). Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scandinavian journal of immunology, 63(3), 155-168.
Hori, Y., Yamada, K., Hanafusa, N., Okuda, T., Okada, N., Miyata, T., ... & Nangaku, M. (1999). Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney international, 56(6), 2096-2106..
Springall, T., Sheerin, N. S., Abe, K., Holers, V. M., Wan, H., & Sacks, S. H. (2001). Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nature medicine, 7(7), 801-806.
Ritchie, R. F., Palomaki, G. E., Neveux, L. M., Navolotskaia, O., Ledue, T. B., & Craig, W. Y. (2004). Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. Journal of clinical laboratory analysis, 18(1), 1-8.
Li, K., Feito, M. J., Sacks, S. H., & Sheerin, N. S. (2006). CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. The Journal of Immunology, 177(4), 2543-2551.
Silhavy, T. J., Kahne, D., & Walker, S. (2010). The bacterial cell envelope. Cold Spring Harbor perspectives in biology, 2(5), a000414.
Berends, E. T., Kuipers, A., Ravesloot, M. M., Urbanus, R. T., & Rooijakkers, S. H. (2014). Bacteria under stress by complement and coagulation. FEMS microbiology reviews, 38(6), 1146-1171.
Zipfel, P. F., Hallstroem, T., & Riesbeck, K. (2013). Human complement control and complement evasion by pathogenic microbes–tipping the balance. Molecular immunology, 56(3), 152-160.
Hyams, C., Camberlein, E., Cohen, J. M., Bax, K., & Brown, J. S. (2010). The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infection and immunity, 78(2), 704-715.
Matsuura, M. (2013). Structural modifications of bacterial lipopolysaccharide that facilitate gram-negative bacteria evasion of host innate immunity. Frontiers in immunology, 4, 109.
Lambris, J. D., Ricklin, D., & Geisbrecht, B. V. (2008). Complement evasion by human pathogens. Nature Reviews Microbiology, 6(2), 132-142.
Garcia, B. L., Zhi, H., Wager, B., Höök, M., & Skare, J. T. (2016). Borrelia burgdorferi BBK32 inhibits the classical pathway by blocking activation of the C1 complement complex. PLoS pathogens, 12(1), e1005404.
Hammel, M., Sfyroera, G., Pyrpassopoulos, S., Ricklin, D., Ramyar, K. X., Pop, M., ... & Geisbrecht, B. V. (2007). Characterization of Ehp, a secreted complement inhibitory protein from Staphylococcus aureus. Journal of Biological Chemistry, 282(41), 30051-30061..
de Haas, C. J., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J., Heezius, E. C., ... & Van Strijp, J. A. (2004). Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. The Journal of experimental medicine, 199(5), 687-695.
Fernie‐King, B. A., Seilly, D. J., Willers, C., Würzner, R., Davies, A., & Lachmann, P. J. (2001). Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology, 103(3), 390-398..
How to Cite
Copyright (c) 2023 Shahrazad Ahmed Khalaf, Mohammed Abdul Daim Saleh, Nibras Nazar Mahmood , Eman A. Muhsin
This work is licensed under a Creative Commons Attribution 4.0 International License.
AJB is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.